Clinical Trials Browser

Interventional × Pharmacogenomic Testing × 30 days × Clear all

NCT02399371 2026-05-08

Pembrolizumab in Treating Patients With Malignant Mesothelioma

Phase 2 Completed

65 enrolled 12 charts

Other solid neoplasmThoracic

Mesothelioma, Malignant, Solitary Fibrous Tumor, Pleural

NCT06511401 2026-05-04

C-PAIN

Phase NA Recruiting

Adult Patients Who Are Receiving Oncologic Care